Vietnam is rapidly strengthening its position as a destination for international clinical research, creating significant opportunities for the clinical trial supplies sector. Industry estimates indicate the market is currently valued at US$18–28 million and is projected to reach US$35–50 million by 2030, representing annual growth of 12–15%.
The market's expansion is being driven by increasing investment from global pharmaceutical and biotechnology companies, a growing number of multinational clinical trials, and continued improvements to Vietnam's healthcare and regulatory landscape. With a large treatment-naïve patient population, internationally recognised hospitals and competitive operating costs, Vietnam is becoming an increasingly attractive location for Phase II, III and IV clinical studies.
As clinical research activity grows, so too does demand for specialist clinical trial supply services. This includes investigational medicinal product (IMP) distribution, comparator drug sourcing, temperature-controlled logistics, clinical packaging and labelling, biological sample transport, depot management and regulatory support. The increasing use of biologics, advanced therapies and decentralised clinical trials is also driving investment in sophisticated cold-chain and direct-to-patient supply capabilities.
Vietnam's broader pharmaceutical sector is forecast to continue expanding, supported by government initiatives to strengthen healthcare innovation, encourage research and development, and attract international investment. Regulatory reforms and greater collaboration between healthcare institutions, research organisations and industry are further enhancing the country's appeal as a regional clinical research hub.
For companies operating across pharmaceutical manufacturing, biotechnology, clinical research, logistics and laboratory services, the market presents substantial opportunities to support Vietnam's growing clinical development ecosystem and contribute to faster access to innovative medicines.
As demand for clinical research continues to accelerate across Southeast Asia, Vietnam is well positioned to become one of the region's leading centres for clinical trials, supported by a modern, resilient and increasingly sophisticated clinical trial supply chain.
